Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0000905148-26-003499

Chief Financial Officer sold 1,142 shares at $1.57 ($1,793)

From the SEC's structured data for this filing

Trades in this filing

Levy Adam D. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-04 Sale : show line 1 in the form −1,142 $1.57 $1,793 66,008 D
Open-market sales · 1,142 sh · avg $1.57 · $1,793
Loading xslF345X06/form4.xml…